Andrew J. Perlman serves as Executive at ISTA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Andrew J. Perlman has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 6, 2024 involved receiving (via award) 8,400 shares valued at $0.
Andrew J. Perlman currently holds 29,325 shares of ISTA PHARMACEUTICALS INC (ISTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew J. Perlman has been a net neutral trader of ISTA stock. They have purchased $0 and sold $0 worth of shares.
Andrew J. Perlman's most recent insider trade was on Jun 6, 2024, when they sold 8,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 14, 2022 | RCUS | $0 | Award | 4,100 | $N/A | Discretionary |
| Jun 3, 2021 | RCUS | $0 | Award | 3,000 | $N/A | Discretionary |
| Dec 17, 2020 | RCUS | $0 | Award | 4,500 | $N/A | Discretionary |
| Jun 6, 2012 | ISTA | $44.9K | Disposition | 4,932 | $9.10 | Discretionary |
| Dec 10, 2008 | ISTA | $0 | Award | 2,466 | $N/A | Discretionary |
| Oct 11, 2007 | ISTA | $0 | Award | 2,466 | $N/A | Discretionary |